Wave Life Sciences
WVE
132 hedge funds and large institutions have $572M invested in Wave Life Sciences in 2024 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 54 increasing their positions, 32 reducing their positions, and 16 closing their positions.
279% more call options, than puts
Call options by funds: $549K | Put options by funds: $145K
113% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 16
69% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 32
22% more capital invested
Capital invested by funds: $468M → $572M (+$104M)
15% more funds holding
Funds holding: 115 → 132 (+17)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1.89% less ownership
Funds ownership: 77.75% → 75.86% (-1.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$5.61M |
| 2 |
AG
Artal Group
Luxembourg
|
+$5.23M |
| 3 |
BlackRock
New York
|
+$5.05M |
| 4 |
Morgan Stanley
New York
|
+$3.78M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$2.95M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$9.5M |
| 2 |
MS
Maven Securities
St Helier,
Jersey
|
-$7.34M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.2M |
| 4 |
Primecap Management
Pasadena,
California
|
-$4.42M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.94M |
WVE Hedge Fund Activity: Q1 2024 in Review
132 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q1 2024, worth a combined $572M — up 22% from $468M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new WVE positions and 16 closed out — a net gain of 18 holders — while 54 added to existing stakes and 32 trimmed.
The largest buyer was Millennium Management, adding an estimated $5.61M. The largest seller was Citadel Advisors, cutting an estimated $9.5M.
- 132 institutional investors held Wave Life Sciences (WVE) as of Q1 2024, up from 115 in Q4 2023.
- Funds reported $572M of Wave Life Sciences stock for Q1 2024, up 22% quarter-over-quarter.
- 34 funds opened new Wave Life Sciences positions in Q1 2024 and 16 closed out, a net change of +18 holders.
- The largest Wave Life Sciences buyer in Q1 2024 was Millennium Management, an estimated $5.61M added.
- The largest Wave Life Sciences seller in Q1 2024 was Citadel Advisors, an estimated $9.5M sold.
Based on aggregated 13F filings for Q1 2024.